1. Home
  2. ETD vs RCUS Comparison

ETD vs RCUS Comparison

Compare ETD & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETD
  • RCUS
  • Stock Information
  • Founded
  • ETD 1932
  • RCUS 2015
  • Country
  • ETD United States
  • RCUS United States
  • Employees
  • ETD N/A
  • RCUS N/A
  • Industry
  • ETD Home Furnishings
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETD Consumer Discretionary
  • RCUS Health Care
  • Exchange
  • ETD Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • ETD 709.8M
  • RCUS 727.1M
  • IPO Year
  • ETD 1993
  • RCUS 2018
  • Fundamental
  • Price
  • ETD $26.51
  • RCUS $7.88
  • Analyst Decision
  • ETD Hold
  • RCUS Strong Buy
  • Analyst Count
  • ETD 2
  • RCUS 10
  • Target Price
  • ETD $32.00
  • RCUS $29.50
  • AVG Volume (30 Days)
  • ETD 326.1K
  • RCUS 1.2M
  • Earning Date
  • ETD 05-05-2025
  • RCUS 05-07-2025
  • Dividend Yield
  • ETD 5.89%
  • RCUS N/A
  • EPS Growth
  • ETD N/A
  • RCUS N/A
  • EPS
  • ETD 2.39
  • RCUS N/A
  • Revenue
  • ETD $626,650,000.00
  • RCUS $258,000,000.00
  • Revenue This Year
  • ETD N/A
  • RCUS N/A
  • Revenue Next Year
  • ETD $2.47
  • RCUS $25.77
  • P/E Ratio
  • ETD $11.09
  • RCUS N/A
  • Revenue Growth
  • ETD N/A
  • RCUS 120.51
  • 52 Week Low
  • ETD $24.55
  • RCUS $6.50
  • 52 Week High
  • ETD $35.62
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • ETD 46.33
  • RCUS 44.26
  • Support Level
  • ETD $25.77
  • RCUS $6.75
  • Resistance Level
  • ETD $27.39
  • RCUS $8.36
  • Average True Range (ATR)
  • ETD 1.34
  • RCUS 0.60
  • MACD
  • ETD -0.02
  • RCUS 0.16
  • Stochastic Oscillator
  • ETD 55.21
  • RCUS 74.19

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: